ISI Expands Global Presence With Opening of Tianjin, China Office

ISI Expands Global Presence With Opening of Tianjin, China Office

May 29, 2007

New Operation Bolsters ISI's Global Support Capabilities in
Response to Clients' Growing Presence in Asian Markets and
Increased Need for Speed


    WHIPPANY, N.J., May 29 /Xinhua-PRNewswire/ -- Image
Solutions Inc., (ISI), a leader in providing software and
services to streamline the drug development lifecycle,
announced today the opening of new operations in Tianjin,
China. ISI's expansion in Asia supports the company's
overall commitment to support the globalization of the Life
Science Industry.  The China operation adds to ISI's already
strong capabilities that exist in Asia through its
development center in Korea, testing and support
capabilities in India, and in Japan through an alliance
with CAC Corporation.

    (Logo: 
http://www.newscom.com/cgi-bin/prnh/20070206/NYTU010LOGO )

    ISI is enhancing its global capabilities to keep pace
with its clients' needs to respond to increased regulatory
pressures, the need to reduce overall costs, and the
requirement to speed submission timetables.  In addition,
China has emerged as a preferred location for new markets
and lower-cost drug development and manufacturing.
Accordingly, ISI is well positioned for the anticipated
growth in this region. 

    The opening of the operation also represents a
strategic decision on ISI's part to blend global resources
and services providing unprecedented support for client
requirements.  For ISI clients, the foremost Life Science
organizations in the world, each day of document processing
translates into potential lost revenues downstream. 

    To satisfy this demand for speed and efficiency, ISI
can now link multiple offices located in different time
zones, and use web-based technology to provide almost 400
man-hours of production time within a single 24 hour day.
This capability provides ISI with a unique competitive
advantage to meet client timeframes and achieve their goals
quickly and cost-effectively.  

    The focus for the China operation in the short term is
CRF Processing.  CRFs are the most paper-intensive document
process in the Life Science industry with more than five
million CRF pages generated each week.  CRF processing has
been the backbone of ISI services since its inception.  To
date, ISI has processed more than 50 million pages of CRFs
for submission to the FDA.  ISI's CRF services are part of
a broad portfolio of business process outsourcing services
developed to assist companies in reducing the time and cost
associated with compiling electronic submissions, managing
data, and preparing scientific documents.

    Because of ISI's ongoing commitment to quality, the
operation in China is expected to be ISO certified later in
2007. ISO is a global, centrally managed certification given
after rigorous review of standard operating procedures and
the assurance that all processes and procedures are
centrally controlled. These methods help ISI provide
predictable project estimates and stable, high-quality
deliverables and demonstrate ISI's strong commitment to
quality by achieving the highest industry standard. 

    With record performance over the past several years,
ISI is aggressively growing operations in the United
States, Europe and Asia. This year alone, ISI plans to
expand it's presence in the United States with the opening
of operations in two primary biotechnology hotbed regions:
Boston, Massachusetts, and San Diego, California. In
Europe, ISI will have an increased presence in the United
Kingdom. 
    
    About Image Solutions, Inc.

    Founded in 1992, Image Solutions, Inc (ISI) is a proven
market leader in providing submissions solutions, process
services and consulting to Life Sciences companies as a way
to improve clinical and regulatory processes that bring new
medicines to market. ISI was among the first professional
services firm to deliver electronic submissions to the
industry and since has delivered nearly 1,000 electronic
submissions and 400 eCTD submissions. ISI serves the top 50
pharmaceutical and biotech organizations as well as the top
companies in other regulated industries.

    ISI is a privately held company with headquarters in
Whippany, New Jersey and operations throughout the U.S.,
Europe and Asia. ISI also remains committed to giving back
to society and sharing its success with others by donating
10 percent of annual net profits to over 20 recognized
charitable organizations. For more information, visit the
company website at http://www.imagesolutions.com


    For more informtion, please contact:

     Keith W. Ward, Associate Director, 
     Global Marketing, 
     Image Solutions, Inc.
     Tel:  [phone] x324
     Fax:  [phone]